Where does Oscor Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Oscor Inc. ranks #12,156 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Oscor Inc. hold?

Oscor Inc. holds 25 US utility patents granted between 2015 and 2025, spanning 7 technology areas.

What is Oscor Inc.'s Innovation Score?

Oscor Inc. has an Innovation Score of 40.6 out of 100 (top 35% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Oscor Inc.'s patent grant rate increasing or decreasing?

Oscor Inc.'s recent grant velocity is +9% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Oscor Inc.'s patents?

Oscor Inc.'s patents average 13.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Oscor Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Oscor Inc.

Q: What technology areas does Oscor Inc. focus on?

Oscor Inc.'s top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 12 patents, ranking #592 of 3,490 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 25 granted patents across 7 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Oscor ranks #12,156 of 49,997 tracked US assignees by granted-patent volume, with 25 patents across 7 technology areas.

#12,156
of 49,997 US assignees by volume: Top 35%
by Innovation Score (40.6/100): 13.4
avg claims per patent: +9%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12156 · US Corporation #12,156 · 25 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 25 grants
UPPER-Q #12,156/49,997
PHOTO-FINISH Obalon Therapeutics
CPC-NARROW A61M · 7 areas
INNOV-PAR 40.6/100
CLAIMS-RICH 13.4 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +9% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Obalon Therapeutics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Oscor’s 40.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.3 pts (28%) Velocity 12.0 pts (29%) Breadth 9.4 pts (23%) Claim depth 8.0 pts (20%)

Qualcomm Incorporated · highest

85
Airex · near

41
Fluidity · near

41
OBI Pharma · near

41
Oscor · this assignee

41
Selecta Biosciences · near

41
3D Lighting… · lowest

7

What this shows Oscor's Innovation Score is 40.6/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Oscor?

Each dot is one of Oscor’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Oscor’s own 13.4 claims/patent is ABOVE the 11.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Oscor vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Oscor's grants concentrate

Oscor Inc. is a focused PatentsView assignee: 7 CPC subclasses with 48% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2016. By volume, Oscor sits between Obalon Therapeutics, Inc. and P.S. Pibbs, Inc..

Oscor's three-year grant acceleration

Oscor Inc. shows 9 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Obalon Therapeuti…

25
Oetiker Schweiz

25
Onyx Therapeutics

25
Optodot

25
Out Rage

25
Outrider

25
Owen Oil Tools

25
P S Pibbs

25
Oscor ◀

25

What this shows Oscor holds 25 patents at rank #12,153, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Oscor

By rank, the assignees closest to #12,153 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Oscor's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Oscor, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Oscor ranks #592 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

OBI Pharma, Inc. 41 Airex Co., Ltd. 41 Selecta Biosciences, Inc. 41 Fluidity Technologies Inc. 41

Oscor's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Oscor Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	8.0%
2016	1	4.0%
2017	4	16.0%
2018	2	8.0%
2019	2	8.0%
2020	1	4.0%
2021	2	8.0%
2022	4	16.0%
2023	1	4.0%
2024	4	16.0%
2025partial year	2	8.0%

Which technologies does Oscor Inc. patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 12

A61B - DIAGNOSIS; SURGERY; Identification 9

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 5

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 4

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 4

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 2

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Oscor Inc.'s patent record in context - here's where to go next.

Oscor Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 48% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #12,156 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Oscor Inc. against Obalon Therapeutics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.